Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Heatmap
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
KRYS
#878
Krystal Biotech, Inc. - Common Stock
363.4
4
USD
-0.01%
Sector:
Healthcare
Base:
USD
Profit Currency:
USD
Daily Range
Year Range
Daily Change
-0.65%
Monthly Change
+14.29%
6 month change
+23.20%
Year Change
+94.22%
Previous Close
365.8
1
Open
363.4
4
Low
363.4
4
High
363.4
4
Volume
97
Markets
US Stock Market
Healthcare
Biotechnology
KRYS
1W
1M
3M
6M
YTD
1Y
5Y
Open full chart
Financials
Overview
Statement
Statistics
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
Current
Key stats
Total common shares outstanding
22.19 M
25.21 M
25.76 M
28.29 M
28.81 M
29.23 M
29.48 M
Valuation ratios
Enterprise value
1.06 B
1.42 B
1.88 B
3.18 B
4.17 B
6.71 B
10.61 B
Price to earnings ratio
—
-22.35
-14.43
320.41
52.22
36.04
50.47
Price to sales ratio
—
—
28.05 K
68.4
16.04
18.98
27.13
Price to cash flow ratio
—
-32.39
-20.08
39.05
37.75
36.76
45.29
Price to book ratio
—
2.62
3.87
4.45
4.92
6.05
2.42
Enterprise value to EBITDA ratio
-34.1
-21.71
-13.31
-30.71
58.16
40.18
57.48
Profitability ratios
Return on assets %
-0.1
-0.11
-0.25
0.01
0.08
0.15
0.04
Return on equity %
-0.11
-0.12
-0.27
0.01
0.09
0.17
0.04
Return on invested capital %
-411.43
-220.38
-293.7
-156.2
67.23
140.39
36.82
Gross margin %
100
—
100
100
100
100
100
Operating margin %
100 K
—
201.66 K
-216.43
22.61
41.45
46.14
EBITDA margin %
94.49 K
—
196.13 K
-204.03
24.67
42.92
47.45
Net margin %
97.48 K
—
194.41 K
21.56
30.69
52.64
48.07
Liquidity ratios
Quick ratio
—
—
—
17.55
7.02
9.56
9.06
Current ratio
17.8
17.18
13.3
17.76
7.28
9.95
9.46
Inventory turnover
—
—
—
—
—
—
—
Asset turnover
-0
0
-0
0.07
0.31
0.29
0.09
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
—
-2.16
-3.95
-3.2
4.15
6.71
8.32
EBIT per share
—
-3.08
-5.69
-3.95
2.21
5.39
5.95
EBITDA per share
—
-2.95
-5.54
-3.73
2.41
5.58
6.15
Total debt per share
—
—
—
—
—
—
—
Cash per share
—
19.74
14.88
19.18
20.09
27.64
26.99
Net current asset value per share
—
19.92
15.06
21.18
24.95
34.21
33.43
Tangible book value per share
—
26.74
20.49
28.06
31.82
40.72
41.85
Working capital per share
—
18.77
13.92
19.99
21.52
30.77
29.89
Book value per share
—
26.74
20.49
28.06
31.82
40.72
41.85
News
Argenx, Stock Of The Day, Eyes Buy Point Amid Triple-Digit Growth
Krystal Biotech (KRYS) Soars 3.4%: Is Further Upside Left in the Stock?
Entertainment Stocks Madison Square Garden, Sphere Rally To New Highs
Stock Market Week Ahead: Keep An Eye On The Little Things
Viking, Bloom Energy Lead Five Stocks Making Bullish Moves As Market Rebounds
Dow Jones Futures Rise After Big Trump Rally; SpaceX IPO To Launch After Pricing IPO
Is the Options Market Predicting a Spike in Krystal Biotech Stock?
Why Is Techne (TECH) Up 4.5% Since Last Earnings Report?
Why Is Cytokinetics (CYTK) Down 5.5% Since Last Earnings Report?
Krystal Biotech Stock Soars 16% in Three Months: Here's Why
Caterpillar Plows Ahead, Hits Fresh High. Leads 19 Top Performers To Best Stock Lists.
Why Is Krystal Biotech (KRYS) Up 3% Since Last Earnings Report?